HRZE Dosing for 45 kg Patient
For a patient weighing 45 kg with creatinine clearance of 63 mL/min, administer the following daily doses: Isoniazid 300 mg, Rifampin 450 mg, Pyrazinamide 1000 mg, and Ethambutol 800 mg. 1
Weight-Based Dosing Breakdown
For a 45 kg patient, the standard daily regimen falls into the 40-55 kg weight band according to established guidelines 1, 2:
- Isoniazid: 5 mg/kg = 225 mg, rounded to standard dose of 300 mg daily (maximum dose)
- Rifampin: 10 mg/kg = 450 mg = 450 mg daily (use 450 mg formulation for patients <50 kg)
- Pyrazinamide: 15-30 mg/kg = 675-1350 mg, use 1000 mg daily (18.2-25.0 mg/kg range for 40-55 kg band)
- Ethambutol: 15 mg/kg = 675 mg, use 800 mg daily (14.5-20.0 mg/kg range for 40-55 kg band)
Renal Function Considerations
With a creatinine clearance of 63 mL/min (mild renal impairment):
- Isoniazid and Rifampin: No dose adjustment needed; give standard doses 3
- Pyrazinamide: No adjustment required at CrCl >50 mL/min; standard dosing applies 3
- Ethambutol: Critical consideration - while no formal adjustment is required at CrCl 63 mL/min, ethambutol requires dose adjustment or increased dosing intervals when CrCl falls below 50 mL/min due to risk of optic neuritis 3. At 63 mL/min, standard daily dosing is appropriate, but monitor renal function closely.
Treatment Duration and Monitoring
Standard 6-month regimen: 2 months of HRZE (intensive phase) followed by 4 months of HR (continuation phase) 1. The intensive phase should deliver 56 doses within 8 weeks, and continuation phase should deliver 126 doses within 18 weeks 1.
Key Monitoring Points:
- Monthly sputum cultures until two consecutive negatives 1
- Visual acuity and color discrimination monthly while on ethambutol 1
- Hepatic function at baseline and if symptoms develop (not routine monthly monitoring unless baseline abnormalities) 1
- Renal function monitoring is particularly important in this patient given borderline CrCl - check monthly to ensure ethambutol dosing remains appropriate 3
Important Caveats
Cavitation on chest X-ray: If initial chest radiograph shows cavitation AND sputum culture remains positive at 2 months, extend continuation phase to 7 months (total 9 months treatment) 1
HIV co-infection: If CD4 count <100 cells/μL, avoid once-weekly dosing in continuation phase; use daily or three-times-weekly dosing only 1
Pyridoxine supplementation: Add vitamin B6 25-50 mg daily with isoniazid to prevent peripheral neuropathy 4, 5
Practical Administration
All medications should be taken together as a single daily dose on an empty stomach (30 minutes before or 2 hours after meals) to optimize absorption 6, 7. If the patient cannot tolerate fasting administration due to gastrointestinal upset, taking with food is acceptable but may slightly reduce absorption 1.